Senegal vs South Sudan: Population requiring preventive chemotherapy for schistosomiasis
Senegal
3.38 million
in 2024
South Sudan
3.75 million
in 2024
Senegal rank
23rd
South Sudan rank
22nd
Population requiring preventive chemotherapy for schistosomiasis over time
- Senegal
- South Sudan
How they compare
South Sudan currently reports 3.75 million against 3.38 million in Senegal, a difference of 371,740.
That makes South Sudan's figure about 1.1 times Senegal's.
The two have swapped places 1 time across 12 shared years of data; in 2013 it was Senegal ahead.
Senegal ranks 23rd and South Sudan ranks 22nd of 52 countries.
Across the 2 decades both report, Senegal averaged higher in 1 and South Sudan in 1.
Head to head by decade
| Decade | Senegal | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 3.70 million | 2.57 million | 1.12 million | Senegal |
| 2020s | 2.93 million | 3.48 million | 545,986 | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Senegal or South Sudan?
- South Sudan, at 3.75 million against 3.38 million in Senegal as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Senegal and South Sudan?
- 371,740, with South Sudan ahead.
- How many years of comparable data are there for Senegal and South Sudan?
- 12 years are reported by both, from 2013 to 2024.
- How do Senegal and South Sudan rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Senegal ranks 23rd and South Sudan ranks 22nd of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.